Updates:

Latest update: July 2023

• New cases
• New panel appropriateness ratings
• Extra PinPoint cases added
• Guidelines updated: EAU 2023, NCCN v3.2023 on bladder cancer and NCCN v2.2023 on toxicities related to immunotherapy
• Guidelines added: ESMO-EONS-EANO 2020, ASCO 2020 on anticancer therapy-induced peripheral neurotoxicity
• Evidence updated

Update: December 2022

• Guidelines updated: EAU 2022, NCCN v2.2022 on bladder cancer and ESMO 2022, ASCO 2021, NCCN v1.2022 on toxicities related to immunotherapy
• Minor textual changes

Update: April 2021

• Guidelines added: NCCN v1.2021 on management of immunotherapy-related toxicities, ESMO on bladder cancer
• Guidelines updated: EAU 2021, NCCN v2.2021 on bladder cancer
• Evidence updated

July 2020

• Topic created